Upstream Bio UPB Growth Metrics (2023-2026)

NASDAQ UPB
$3.20 -0.18 (-5.33%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Upstream Bio Quarterly Growth Metrics

Periods 12 quarters
Latest Sep 2026

Upstream Bio reported revenue growth of -14.00% and asset growth of -37.12% for the quarter ended Sep 2026. These growth metrics cover 12 quarters of results from Dec 2023 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Growth Ratios
Share-based Compensation (QoQ)Stock Comp. (QoQ) 19.03%-20.91%119.60%31.94%11.97%26.32%-1.44%-0.12%-3.39%85.43%-6.31%-0.21%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y) 85.29%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y) 172.77%156.58%309.80%83.92%39.24%20.13%76.36%67.65%67.50%
Revenue (QoQ) -27.54%42.22%-20.31%19.02%0.99%-7.67%65.55%-27.11%-2.20%54.79%-25.24%-48.90%
Revenue Growth (3y) -14.00%
Revenue Growth (1y) -2.25%36.22%-11.56%83.73%12.52%8.97%82.69%-17.50%-42.17%
Return on Sales [ROS] (QoQ)ROS (QoQ) -0.17M0.08M-0.11M0.03M-0.12M-0.14M0.09M-0.08M-0.14M0.27M-0.13M-0.55M
Return on Sales [ROS] Growth (3y)ROS Growth (3y) -0.95M
Return on Sales [ROS] Growth (1y)ROS Growth (1y) -0.16M-0.11M-0.33M-0.13M-0.24M-0.26M0.14M-0.07M-0.54M
Return on Equity [ROE] (QoQ)ROE (QoQ) 0.00M-717.00-663.00-877.00-900.00-579.000.00M
Return on Equity [ROE] Growth (1y)ROE Growth (1y) 83.000.00M0.00M0.00M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) 182.00-781.00-722.00-900.00-870.00-533.000.00M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) 0.00M0.00M0.00M0.00M
Return on Assets [ROA] (QoQ)ROA (QoQ) 79.00-696.00-632.00-828.00-839.00-561.000.00M
Return on Assets [ROA] Growth (1y)ROA Growth (1y) 0.00M0.00M0.00M0.00M
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) 0.69%-7.39%0.93%13.24%-9.25%-8.77%-9.80%-10.65%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) 266.04%6.57%-3.95%-5.38%-15.44%-33.28%
Operating Margin (QoQ) -0.17M0.08M-0.11M0.03M-0.12M-0.14M0.09M-0.08M-0.14M0.27M-0.13M-0.55M
Operating Margin Growth (3y) -0.95M
Operating Margin Growth (1y) -0.16M-0.11M-0.33M-0.13M-0.24M-0.26M0.14M-0.07M-0.54M
Operating Income (QoQ)Op. Inc (QoQ) -52.67%-4.77%-16.83%-7.71%-39.30%-21.64%-38.53%14.69%-22.03%5.53%2.86%-2.39%
Operating Income Growth (3y)Op. Inc Growth (3y) -66.57%
Operating Income Growth (1y)Op. Inc Growth (1y) -101.29%-83.66%-113.24%-152.83%-100.25%-75.42%-36.24%4.46%-14.66%
Net Margin (QoQ) -0.23M0.11M-0.16M0.04M-0.01M-0.13M0.06M-0.07M-0.14M0.24M-0.12M-0.53M
Net Margin Growth (3y) -0.94M
Net Margin Growth (1y) -0.25M-0.02M-0.26M-0.04M-0.15M-0.28M0.09M-0.09M-0.55M
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) -139.63%6.50%-39.63%-7.52%-3.60%-25.15%-46.56%15.56%-25.81%4.40%2.19%-3.75%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y) -87.46%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) -236.37%-45.42%-94.65%-104.30%-60.45%-94.86%-48.85%0.66%-22.06%
Net Income (QoQ) -279.14%7.94%-34.73%-8.95%-32.83%-28.38%-46.56%15.56%-25.81%4.40%2.19%-3.75%
Net Income Growth (3y) -136.32%
Net Income Growth (1y) -412.40%-79.51%-150.32%-172.29%-111.03%-99.88%-48.85%0.66%-22.06%
Net Cash Flow (QoQ)NCF (QoQ) 126.42%178.77%-189.69%2,163.86%-186.90%89.84%203.30%10.14%-116.50%-256.96%-84.57%
Net Cash Flow Growth (1y)NCF Growth (1y) 1,463.48%-4,584.41%-263.36%288.15%-89.96%98.09%32.98%-219.75%
Income After Tax (QoQ) -63.01%-7.31%-6.66%-9.04%-32.85%-28.38%-46.37%15.50%-26.04%4.59%2.10%-3.63%
Income After Tax Growth (3y) -73.65%
Income After Tax Growth (1y) -103.45%-65.81%-98.37%-172.22%-110.95%-100.14%-48.74%0.52%-22.00%
Gross Profit (QoQ) -413.49%-73.51%-36.58%27.20%-479.85%79.49%-312.80%48.67%16.43%
Gross Profit Growth (1y) -640.83%-900.33%-18.26%-257.43%-152.02%63.68%
Gross Margin (QoQ) -0.02M-0.01M-0.01M0.01M-0.07M0.07M-0.09M0.08M0.00M
Gross Margin Growth (1y) -0.03M-0.08M0.00M-0.08M-0.01M0.05M
Free Cash Flow (QoQ)FCF (QoQ) -9.01%54.24%-73.74%-41.79%-107.94%4.68%43.16%-37.58%-55.95%25.56%-52.24%
Free Cash Flow Growth (1y)FCF Growth (1y) -22.89%-134.40%-388.29%-59.75%-55.00%-16.24%9.22%-143.14%
FCF Margin (QoQ) 0.08M0.12M-0.07M-0.09M-0.40M0.31M0.09M-0.13M0.00M0.00M-0.91M
FCF Margin Growth (1y) 0.04M-0.45M-0.26M-0.10M-0.14M0.26M-0.04M-1.05M
EPS (Diluted) (QoQ) -140.03%7.81%-39.02%-7.01%77.11%68.06%-46.14%15.81%-25.99%5.24%2.61%-3.35%
EPS (Diluted) Growth (3y) 29.14%
EPS (Diluted) Growth (1y) -229.20%68.61%89.13%88.57%91.01%50.49%-46.89%2.11%-20.16%
EPS (Basic) (QoQ) -140.03%7.81%-39.02%-7.01%77.11%68.06%-46.14%15.81%-25.99%5.24%2.61%-3.35%
EPS (Basic) Growth (3y) 29.14%
EPS (Basic) Growth (1y) -229.20%68.61%89.13%88.57%91.01%50.49%-46.89%2.11%-20.16%
EBT (QoQ) -63.01%-7.31%-6.66%-9.04%-32.85%-28.38%-46.37%15.50%-26.04%4.59%2.10%-3.63%
EBT Margin (QoQ) -0.16M0.07M-0.07M0.02M-0.08M-0.14M0.06M-0.07M-0.14M0.24M-0.12M-0.53M
EBT Margin Growth (3y) -0.92M
EBT Margin Growth (1y) -0.14M-0.06M-0.27M-0.14M-0.23M-0.29M0.09M-0.09M-0.55M
EBT Growth (3y) -73.65%
EBT Growth (1y) -103.45%-65.81%-98.37%-172.22%-110.95%-100.14%-48.74%0.52%-22.00%
EBIT (QoQ) -52.67%-4.77%-16.83%-7.71%-39.30%-21.64%-38.53%14.69%-22.03%5.53%2.86%-2.39%
EBIT Margin (QoQ) -0.17M0.08M-0.11M0.03M-0.12M-0.14M0.09M-0.08M-0.14M0.27M-0.13M-0.55M
EBIT Margin Growth (3y) -0.95M
EBIT Margin Growth (1y) -0.16M-0.11M-0.33M-0.13M-0.24M-0.26M0.14M-0.07M-0.54M
EBIT Growth (3y) -66.57%
EBIT Growth (1y) -101.29%-83.66%-113.24%-152.83%-100.25%-75.42%-36.24%4.46%-14.66%
EBITDA Margin (QoQ) 0.08M-0.12M0.05M-0.10M-0.18M0.11M-0.07M-0.11M0.24M-0.12M-0.56M
EBITDA Margin Growth (1y) -0.09M-0.35M-0.12M-0.24M-0.25M0.17M-0.06M-0.55M
Cash from Operations (QoQ)Cash from Ops. (QoQ) -9.01%54.24%-73.74%-40.47%-109.90%4.68%43.32%-37.73%-56.22%25.56%-52.24%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) -21.74%-134.40%-388.29%-59.29%-56.18%-16.24%9.22%-143.84%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ) 364.25%-942.15%101.21%2,874.31%-609.17%105.99%277.25%22.32%-28.06%-62.83%40.73%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y) 899.47%-1,640.43%110.95%3,319.87%40.65%119.87%23.39%-53.97%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) -45.41%21.98%50.23%-30.40%889.11%-78.12%-36.25%58.75%40.76%-4.78%-17.91%-40.28%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y) 0.07%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) -30.37%1,161.53%126.32%-3.97%119.02%-68.83%35.63%74.66%-34.29%
Capital Expenditures (QoQ)Capex (QoQ) -15.63%
Capital Expenditures Growth (1y)Capex Growth (1y) -70.81%
Assets (QoQ) 107.01%-5.30%-7.81%-6.97%-9.57%-10.10%-11.60%-12.51%
Assets Growth (1y) 311.03%68.11%-26.56%-30.28%-33.14%-37.12%

Upstream Bio Growth Metrics API

Pull Upstream Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=UPB&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY